Stefano Ciampolini

Stefano Ciampolini is Adjunct Professor of Imperial College Business School in London and Mentor at Imperial Enterprise Lab’s Venture Mentoring Service as well as a coach at the ETH Innovation & Entrepreneurship Lab in Zurich. Stefano is also a jury member of Venture Kick, Switzerland's largest startup accelerator program.

Stefano is a serial healthcare and medical technology entrepreneur in Europe and the US having founded and successfully exited several companies in the dialysis and renal care sector over the last 20 years.

He is also a managing partner and founder at MedScience Ventures (Boston), a life sciences venture capital fund, and managing partner and founder of Healthcare Capital Partners (London), a private equity and corporate finance advisory boutique specialising in life sciences.

As part of his activities Stefano is a founder, board member and investor in several healthcare and medtech ventures and private equity funds focusing on healthcare investments in Europe and the US. He is founder of Renal Services, a UK dialysis company, a founder and board member of Pure Life Renal, a US dialysis services company, a founder and board member of Biofficient, a bio-procurement platform, a founder and board member of UV Light Care, a US medical devices company and a board member of YoFumo Technologies, a US biomass decontamination company.

Stefano earned an MBA from Imperial College Business School in London in 1994 and holds a degree in economics from Kingston University in London.

At ETH's Chair of Entrepreneurship, Stefano Ciampolini support the mentoring and coaching of technology founders. He interacts with the ETH Innovation & Entrepreneurship Lab and supports in particular the CAS ETH Entrepreneurial Leadership in Technology Ventures.